FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
CH-5183284, 1265229-25-1, CH-5183284 Intermediate 3770-50-1, stock 294.3g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
CH-5183284, 1265229-25-1, CH-5183284 Intermediate 132819-92-2, stock 508.5g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
CH-5183284, 1265229-25-1, CH-5183284 Intermediate 1793076-56-8, stock 821.4g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
CH-5183284, 1265229-25-1, CH-5183284 Intermediate 4637-24-5, stock 640g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
CH-5183284, 1265229-25-1, CH-5183284 Intermediate /, stock 402.2g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
CH-5183284, 1265229-25-1, CH-5183284 Intermediate 73857-55-3, stock 253.3g, white powder, assay by HPLC 98%, HNMR, LCMS we supply. |
CH-5183284, 1265229-25-1, CH-5183284 Intermediate /, stock 182.6g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
CH-5183284, 1265229-25-1, CH-5183284 Intermediate /, stock 707.5g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |